Skip to main content
Top
Published in: Infectious Diseases and Therapy 2/2024

Open Access 24-01-2024 | Septicemia | Original Research

Impact of Invasive Escherichia Coli Disease on Clinical Outcomes and Medical Resource Utilization Among Asian Patients in the United States

Authors: Chao Zhuo, Bo Zheng, Kittima Wattanakamolkul, Yoshikazu Nakayama, Martin Cloutier, Marjolaine Gauthier-Loiselle, Jun Feng, David Wu, Maureen P. Neary, Jeroen Geurtsen, Antoine C. El Khoury, Yoshiaki Gu

Published in: Infectious Diseases and Therapy | Issue 2/2024

Login to get access

Abstract

Introduction

Invasive Escherichia coli disease (IED) can lead to sepsis and death and is associated with a substantial burden. Yet, there is scarce information on the burden of IED in Asian patients.

Methods

This retrospective study used US hospital data from the PINC AI™ Healthcare database (October 2015–March 2020) to identify IED cases among patients aged ≥ 60 years. IED was defined as a positive E. coli culture in blood or other normally sterile body site (group 1 IED) or positive culture of E. coli in urine with signs of sepsis (group 2 IED). Eligible patients with IED were classified into Asian and non-Asian cohorts based on their reported race. Entropy balancing was used to create cohorts with similar characteristics. Outcomes following IED were descriptively reported in the balanced cohorts.

Results

A total of 646 Asian and 19,127 non-Asian patients with IED were included (median age 79 years; 68% female after balancing). For both cohorts, most IED encounters had community-onset (> 95%) and required hospitalization (Asian 96%, mean duration 6.9 days; non-Asian 95%, mean duration 6.8 days), with frequent admission to intensive care (Asian 35%, mean duration 3.3 days; non-Asian 34%, mean duration 3.5 days), all standardized differences [SD] < 0.20. Compared to non-Asian patients, Asian patients were more likely to be discharged home (54% vs. 43%; SD = 0.22), and less likely to be discharged to a skilled nursing facility (24% vs. 31%; SD = 0.16). In-hospital fatality rates during the IED encounter were similar across cohorts (Asian 9%, non-Asian 10%; SD = 0.01). Most E. coli isolates showed resistance to ≥ 1 antibiotic (Asian 61%; non-Asian 64%) and 36% to ≥ 3 antibiotic classes (all SD < 0.20).

Conclusion

IED is associated with a substantial burden, including need for intensive care and considerable mortality, in Asian patients in the USA that is consistent with that observed for non-Asian patients.
Literature
1.
go back to reference Biran D, Ron EZ. Extraintestinal pathogenic Escherichia coli. Curr Top Microbiol Immunol. 2018;416:149–61.PubMed Biran D, Ron EZ. Extraintestinal pathogenic Escherichia coli. Curr Top Microbiol Immunol. 2018;416:149–61.PubMed
2.
go back to reference Doua J, Geurtsen J, Rodriguez-Bano J, et al. Epidemiology, clinical features, and antimicrobial resistance of invasive Escherichia coli disease in patients admitted in tertiary care hospitals. Open Forum Infect Dis. 2023;10(2):ofad026.CrossRefPubMedPubMedCentral Doua J, Geurtsen J, Rodriguez-Bano J, et al. Epidemiology, clinical features, and antimicrobial resistance of invasive Escherichia coli disease in patients admitted in tertiary care hospitals. Open Forum Infect Dis. 2023;10(2):ofad026.CrossRefPubMedPubMedCentral
3.
go back to reference Poolman JT, Wacker M. Extraintestinal pathogenic Escherichia coli, a common human pathogen: challenges for vaccine development and progress in the field. J Infect Dis. 2016;213(1):6–13.CrossRefPubMed Poolman JT, Wacker M. Extraintestinal pathogenic Escherichia coli, a common human pathogen: challenges for vaccine development and progress in the field. J Infect Dis. 2016;213(1):6–13.CrossRefPubMed
4.
go back to reference GBD 2019 Antimicrobial Resistance Collaborators. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400(10369):2221–48.CrossRef GBD 2019 Antimicrobial Resistance Collaborators. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400(10369):2221–48.CrossRef
5.
go back to reference Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2(2):123–40.CrossRefPubMed Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2(2):123–40.CrossRefPubMed
7.
go back to reference Bonten M, Johnson JR, van den Biggelaar AHJ, et al. Epidemiology of Escherichia coli bacteremia: a systematic literature review. Clin Infect Dis. 2021;72(7):1211–9.CrossRefPubMed Bonten M, Johnson JR, van den Biggelaar AHJ, et al. Epidemiology of Escherichia coli bacteremia: a systematic literature review. Clin Infect Dis. 2021;72(7):1211–9.CrossRefPubMed
8.
go back to reference Hernandez-Pastor L, Geurtsen J, Baugh B, et al. Clinical burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States. BMC Infect Dis. 2023;23(1):550.CrossRefPubMedPubMedCentral Hernandez-Pastor L, Geurtsen J, Baugh B, et al. Clinical burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States. BMC Infect Dis. 2023;23(1):550.CrossRefPubMedPubMedCentral
9.
go back to reference Hu FP, Guo Y, Zhu DM, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014. Clin Microbiol Infect. 2016;22(Suppl 1):S9-14.CrossRefPubMed Hu FP, Guo Y, Zhu DM, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014. Clin Microbiol Infect. 2016;22(Suppl 1):S9-14.CrossRefPubMed
10.
go back to reference Ohmagari N, Choi WS, Tang HJ, et al. Targeted literature review of the burden of extraintestinal pathogenic Escherichia coli among elderly patients in Asia Pacific regions. J Med Econ. 2023;26(1):168–78.CrossRefPubMed Ohmagari N, Choi WS, Tang HJ, et al. Targeted literature review of the burden of extraintestinal pathogenic Escherichia coli among elderly patients in Asia Pacific regions. J Med Econ. 2023;26(1):168–78.CrossRefPubMed
11.
go back to reference Tsuzuki S, Matsunaga N, Yahara K, et al. National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan. J Infect Chemother. 2020;26(4):367–71.CrossRefPubMed Tsuzuki S, Matsunaga N, Yahara K, et al. National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan. J Infect Chemother. 2020;26(4):367–71.CrossRefPubMed
12.
go back to reference Jones JM, Fingar KR, Miller MA, et al. Racial disparities in sepsis-related in-hospital mortality: using a broad case capture method and multivariate controls for clinical and hospital variables, 2004–2013. Crit Care Med. 2017;45(12):e1209–17.CrossRefPubMed Jones JM, Fingar KR, Miller MA, et al. Racial disparities in sepsis-related in-hospital mortality: using a broad case capture method and multivariate controls for clinical and hospital variables, 2004–2013. Crit Care Med. 2017;45(12):e1209–17.CrossRefPubMed
13.
go back to reference Ko RE, Suh GY. Factors underlying racial and gender disparities in sepsis management. In: The sepsis codex. St. Louis: Elsevier; 2023. p. 247–55.CrossRef Ko RE, Suh GY. Factors underlying racial and gender disparities in sepsis management. In: The sepsis codex. St. Louis: Elsevier; 2023. p. 247–55.CrossRef
14.
go back to reference Minejima E, Wong-Beringer A. Impact of socioeconomic status and race on sepsis epidemiology and outcomes. J Appl Lab Med. 2021;6(1):194–209.CrossRefPubMed Minejima E, Wong-Beringer A. Impact of socioeconomic status and race on sepsis epidemiology and outcomes. J Appl Lab Med. 2021;6(1):194–209.CrossRefPubMed
15.
go back to reference Prest J, Nguyen T, Rajah T, Prest AB, Sathananthan M, Jeganathan N. Sepsis-related mortality rates and trends based on site of infection. Crit Care Explor. 2022;4(10): e0775.CrossRefPubMedPubMedCentral Prest J, Nguyen T, Rajah T, Prest AB, Sathananthan M, Jeganathan N. Sepsis-related mortality rates and trends based on site of infection. Crit Care Explor. 2022;4(10): e0775.CrossRefPubMedPubMedCentral
17.
go back to reference Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA. 2015;314(10):1021–9.CrossRefPubMed Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA. 2015;314(10):1021–9.CrossRefPubMed
18.
go back to reference Torre LA, Sauer AM, Chen MS Jr, Kagawa-Singer M, Jemal A, Siegel RL. Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: converging incidence in males and females. CA Cancer J Clin. 2016;66(3):182–202.CrossRefPubMedPubMedCentral Torre LA, Sauer AM, Chen MS Jr, Kagawa-Singer M, Jemal A, Siegel RL. Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: converging incidence in males and females. CA Cancer J Clin. 2016;66(3):182–202.CrossRefPubMedPubMedCentral
19.
go back to reference Liu Y, Elliott A, Strelnick H, Aguilar-Gaxiola S, Cottler LB. Asian Americans are less willing than other racial groups to participate in health research. J Clin Transl Sci. 2019;3(2–3):90–6.CrossRefPubMedPubMedCentral Liu Y, Elliott A, Strelnick H, Aguilar-Gaxiola S, Cottler LB. Asian Americans are less willing than other racial groups to participate in health research. J Clin Transl Sci. 2019;3(2–3):90–6.CrossRefPubMedPubMedCentral
21.
go back to reference Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009–2014. JAMA. 2017;318(13):1241–9.CrossRefPubMedPubMedCentral Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009–2014. JAMA. 2017;318(13):1241–9.CrossRefPubMedPubMedCentral
22.
go back to reference Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–82.CrossRefPubMed Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–82.CrossRefPubMed
23.
go back to reference Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–9.CrossRefPubMed Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–9.CrossRefPubMed
24.
go back to reference Hainmueller J. Entropy balancing for causal effects: a multivariate reweighting method to produce balanced samples in observational studies. Polit Anal. 2012;20(1):25–46.CrossRef Hainmueller J. Entropy balancing for causal effects: a multivariate reweighting method to produce balanced samples in observational studies. Polit Anal. 2012;20(1):25–46.CrossRef
25.
go back to reference Harvey RA, Hayden JD, Kamble PS, Bouchard JR, Huang JC. A comparison of entropy balance and probability weighting methods to generalize observational cohorts to a population: a simulation and empirical example. Pharmacoepidemiol Drug Saf. 2017;26(4):368–77.CrossRefPubMed Harvey RA, Hayden JD, Kamble PS, Bouchard JR, Huang JC. A comparison of entropy balance and probability weighting methods to generalize observational cohorts to a population: a simulation and empirical example. Pharmacoepidemiol Drug Saf. 2017;26(4):368–77.CrossRefPubMed
26.
go back to reference Matschinger H, Heider D, Konig HH. A comparison of matching and weighting methods for causal inference based on routine health insurance data, or: what to do if an RCT is impossible. Gesundheitswesen. 2020;82(S02):S139–50.PubMed Matschinger H, Heider D, Konig HH. A comparison of matching and weighting methods for causal inference based on routine health insurance data, or: what to do if an RCT is impossible. Gesundheitswesen. 2020;82(S02):S139–50.PubMed
27.
go back to reference Parish WJ, Keyes V, Beadles C, Kandilov A. Using entropy balancing to strengthen an observational cohort study design: lessons learned from an evaluation of a complex multi-state federal demonstration. Health Serv Outcomes Res Methodol. 2018;18(1):17–46.CrossRef Parish WJ, Keyes V, Beadles C, Kandilov A. Using entropy balancing to strengthen an observational cohort study design: lessons learned from an evaluation of a complex multi-state federal demonstration. Health Serv Outcomes Res Methodol. 2018;18(1):17–46.CrossRef
28.
go back to reference Stuart EA, Lee BK, Leacy FP. Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research. J Clin Epidemiol. 2013;66(8 Suppl):S84-S901e1.CrossRefPubMedPubMedCentral Stuart EA, Lee BK, Leacy FP. Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research. J Clin Epidemiol. 2013;66(8 Suppl):S84-S901e1.CrossRefPubMedPubMedCentral
30.
go back to reference Ma KPK, Bacong AM, Kwon SC, Yi SS, Ethoan LN. The impact of structural inequities on older Asian Americans during COVID-19. Front Public Health. 2021;9: 690014.CrossRefPubMedPubMedCentral Ma KPK, Bacong AM, Kwon SC, Yi SS, Ethoan LN. The impact of structural inequities on older Asian Americans during COVID-19. Front Public Health. 2021;9: 690014.CrossRefPubMedPubMedCentral
31.
go back to reference Hernandez-Pastor L, Geurtsen J, Baugh B, et al. Economic burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States. J Manag Care Spec Pharm. 2023;29(8):873–83.PubMedPubMedCentral Hernandez-Pastor L, Geurtsen J, Baugh B, et al. Economic burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States. J Manag Care Spec Pharm. 2023;29(8):873–83.PubMedPubMedCentral
32.
go back to reference Isenberg SR, Bonares M, Kurahashi AM, Algu K, Mahtani R. Race and birth country are associated with discharge location from hospital: a retrospective cohort study of demographic differences for patients receiving inpatient palliative care. EClinicalMedicine. 2022;45: 101303.CrossRefPubMedPubMedCentral Isenberg SR, Bonares M, Kurahashi AM, Algu K, Mahtani R. Race and birth country are associated with discharge location from hospital: a retrospective cohort study of demographic differences for patients receiving inpatient palliative care. EClinicalMedicine. 2022;45: 101303.CrossRefPubMedPubMedCentral
33.
go back to reference Sharma RK, Khosla N, Tulsky JA, Carrese JA. Traditional expectations versus US realities: first- and second-generation Asian Indian perspectives on end-of-life care. J Gen Intern Med. 2012;27(3):311–7.CrossRefPubMed Sharma RK, Khosla N, Tulsky JA, Carrese JA. Traditional expectations versus US realities: first- and second-generation Asian Indian perspectives on end-of-life care. J Gen Intern Med. 2012;27(3):311–7.CrossRefPubMed
34.
go back to reference Ko M, Newcomer RJ, Bindman AB, Kang T, Hulett D, Spetz J. Changing home care aides: differences between family and non-family care in California Medicaid home and community-based services. Home Health Care Serv Q. 2020;39(1):1–16.CrossRefPubMed Ko M, Newcomer RJ, Bindman AB, Kang T, Hulett D, Spetz J. Changing home care aides: differences between family and non-family care in California Medicaid home and community-based services. Home Health Care Serv Q. 2020;39(1):1–16.CrossRefPubMed
35.
go back to reference Begier E, Rosenthal NA, Gurtman A, Kartashov A, Donald RGK, Lockhart SP. Epidemiology of invasive Escherichia coli infection and antibiotic resistance status among patients treated in US hospitals: 2009–2016. Clin Infect Dis. 2021;73(4):565–74.CrossRefPubMed Begier E, Rosenthal NA, Gurtman A, Kartashov A, Donald RGK, Lockhart SP. Epidemiology of invasive Escherichia coli infection and antibiotic resistance status among patients treated in US hospitals: 2009–2016. Clin Infect Dis. 2021;73(4):565–74.CrossRefPubMed
36.
go back to reference Jacobs ZG, Prasad PA, Fang MC, Abe-Jones Y, Kangelaris KN. The association between limited English proficiency and sepsis mortality. J Hosp Med. 2020;15(3):140–6.CrossRefPubMedPubMedCentral Jacobs ZG, Prasad PA, Fang MC, Abe-Jones Y, Kangelaris KN. The association between limited English proficiency and sepsis mortality. J Hosp Med. 2020;15(3):140–6.CrossRefPubMedPubMedCentral
38.
go back to reference US National Library of Medicine. Clinical Trials.gov. A study of vaccination with 9-valent extraintestinal pathogenic Escherichia coli Vaccine (ExPEC9V) in the prevention of invasive extraintestinal pathogenic Escherichia coli disease in adults aged 60 years and older with a history of urinary tract infection in the past 2 years. https://classic.clinicaltrials.gov/ct2/show/NCT04899336. Accessed 27 Sept 2023. US National Library of Medicine. Clinical Trials.gov. A study of vaccination with 9-valent extraintestinal pathogenic Escherichia coli Vaccine (ExPEC9V) in the prevention of invasive extraintestinal pathogenic Escherichia coli disease in adults aged 60 years and older with a history of urinary tract infection in the past 2 years. https://​classic.​clinicaltrials.​gov/​ct2/​show/​NCT04899336. Accessed 27 Sept 2023.
Metadata
Title
Impact of Invasive Escherichia Coli Disease on Clinical Outcomes and Medical Resource Utilization Among Asian Patients in the United States
Authors
Chao Zhuo
Bo Zheng
Kittima Wattanakamolkul
Yoshikazu Nakayama
Martin Cloutier
Marjolaine Gauthier-Loiselle
Jun Feng
David Wu
Maureen P. Neary
Jeroen Geurtsen
Antoine C. El Khoury
Yoshiaki Gu
Publication date
24-01-2024
Publisher
Springer Healthcare
Published in
Infectious Diseases and Therapy / Issue 2/2024
Print ISSN: 2193-8229
Electronic ISSN: 2193-6382
DOI
https://doi.org/10.1007/s40121-023-00911-0

Other articles of this Issue 2/2024

Infectious Diseases and Therapy 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.